Effect of treatment with botulinum toxin on spasticity
Open Access
- 1 April 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 65 (762) , 208-210
- https://doi.org/10.1136/pgmj.65.762.208
Abstract
Botulinum toxin, a product of Clostridium botulinum, produces presynaptic neuromuscular block by preventing release of acetylcholine from nerve endings. The toxin was injected directly into the skeletal muscles of six patients with severe spasticity due to stroke-related hemiplegia. It produced both subjective and objective improvement. The toxin injections were well tolerated and no significant side effect was reported.This publication has 10 references indexed in Scilit:
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.1988
- Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.British Journal of Ophthalmology, 1987
- DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLISThe Lancet, 1986
- Effect of treatment with botulinum toxin on neurogenic blepharospasm.BMJ, 1985
- Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus SurgeryOphthalmology, 1980
- STROKE REHABILITATION - ANALYSIS OF REPEATED BARTHEL INDEX MEASURES1979
- Grading of spasticity and its effect on voluntary movement.1976
- Botulinum Toxin: Mechanism of Presynaptic BlockadeScience, 1976
- Spasticity: The Fable of a Neurological Demon and the Emperor's New TherapyArchives of Neurology, 1974
- FUNCTIONAL EVALUATION: THE BARTHEL INDEX.1965